1. National Institute for Health and Clinical Excellence. Appraising life-extending, end of life treatments [Internet]. NICE. 2009 Jul. Available from: https://www.nice.org.uk/guidance/gid-tag387/resources/appraising-life-extending-end-of-life-treatments-paper2
2. National Institute for Health and Care Excellence. Discounting of health benefits in special circumstances [Internet]. NICE. 2011 Jul. Available from: https://www.nice.org.uk/guidance/ta235/resources/osteosarcoma-mifamurtide-discounting-of-health-benefits-in-special-circumstances2
3. National Institute for Health and Care Excellence. Consultation paper - value based assessment of health technologies [Internet]. NICE. 2014. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/NICE-guidance/NICE-technology-appraisals/VBA-TA-Methods-Guide-for-Consultation.pdf
4. NHS England Cancer Drugs Fund Team. Appraisal and funding of cancer drugs from July 2016 (including the new Cancer Drugs Fund) - a new deal for patients, taxpayers and industry. NHS England [Internet]. 2016 Jul. Available from: https://www.england.nhs.uk/wp-content/uploads/2013/04/cdf-sop.pdf
5. National Institute for Health and Care Excellence (NICE) and NHS England. Proposals for changes to the arrangements for evaluating and funding drugs and other health technologies appraised through NICE’s technology appraisal and highly specialised technologies programmes [Internet]. NICE and NHS England. 2016 Oct. Available from: https://www.nice.org.uk/Media/Default/About/what-we-do/our-programmes/technology-appraisals/NICE_NHSE_TA_and_HST_consultation_document.pdf